| Name | Title | Contact Details |
|---|
The PWHL is first-of-its-kind womens hockey league that brings together the best players in the world. Our league is comprised of six teams in North America, including: PWHL Boston, PWHL Minnesota, PWHL Montréal, PWHL New York, PWHL Ottawa, and PWHL Toronto.
One of the Worlds Largest Golf Simulator Companies, founded in South Korea in 2000. Winner of five consecutive Golf Digest Awards for Best Golf Simulator (2017-2021). We have over 9,449 sites worldwide, in 41 countries, with 47,500 simulators in operation. Over 99 million rounds are played annually.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.